YWHAE Protein <div class="infobox infobox-protein">
Overview ...
YWHAE Protein <div class="infobox infobox-protein">
Overview The YWHAE gene encodes 14-3-3 epsilon, a member of the 14-3-3 protein family that functions as a critical scaffold and adaptor protein in cellular signaling pathways. The 14-3-3 proteins are highly conserved across eukaryotes and regulate diverse cellular processes including signal transduction, cell cycle progression, [apoptosis](/entities/apoptosis), metabolism, and stress responses [1](https://pubmed.ncbi.nlm.nih.gov/8622923/). In the nervous system, 14-3-3 epsilon plays particularly important roles in neuronal survival, synaptic plasticity, and protection against neurodegeneration [2](https://pubmed.ncbi.nlm.nih.gov/16820411/).
Structure
Protein Architecture 14-3-3 epsilon adopts a distinctive amphipathic groove structure that enables phospho-dependent binding to client proteins:
Nine α-helices (α1-α9) forming a horseshoe-shaped dimerPhosphopeptide-binding groove on each monomer that recognizes phosphorylated serine/threonine motifs (RSXpSXP or pTXY motifs)Dimerization interface at the C-terminus creates a functional dimer with two binding pocketsEach monomer is ~29 kDa; the functional dimer is ~56 kDa
The dimeric structure allows 14-3-3 proteins to simultaneously bind two client proteins, functioning as molecular scaffolds that bring together components of signaling pathways [3](https://pubmed.ncbi.nlm.nih.gov/11025543/).
Seven 14-3-3 isoforms exist in mammals: beta (β), epsilon (ε), eta (η), gamma (γ), theta (θ), zeta/delta (ζ/δ), and sigma (σ). YWHAE is one of the most abundantly expressed isoforms in the brain [4](https://pubmed.ncbi.nlm.nih.gov/11331580/).
Normal Function
Cellular Signaling Regulation 14-3-3 epsilon regulates numerous signaling pathways through phospho-dependent client binding:
RAF-MEK-ERK Pathway:
Binds to and regulates RAF kinases (ARAF, BRAF, CRAF)
Modulates ERK activation downstream of Ras
Influences neuronal differentiation and survival
PI3K-AKT Pathway:
Interacts with AKT/PKB
Modulates cell survival signaling
Important for neuronal viability
Cell Cycle Control:
Binds to CDK-cyclin complexes
Regulates G1/S and G2/M checkpoints
Controls entry into mitosis
Apoptosis Regulation 14-3-3 epsilon is a critical regulator of apoptosis through multiple mechanisms:
BAD Phosphorylation:
Sequesters BAD in the cytoplasm
Prevents BAD from inhibiting anti-apoptotic BCL-2 proteins
Promotes cell survival
ASK1-JNK Pathway:
Modulates stress-activated kinase pathways
Regulates JNK and p38 activation
Controls stress-induced apoptosis
Neuronal Function Synaptic Plasticity:
Regulates [NMDA receptor](/entities/nmda-receptor) trafficking
Modulates AMPA receptor function
Controls [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and depression (LTD)
Involved in learning and memory processes
Axonal Transport:
Binds to microtubule-associated proteins
Regulates motor protein function
Ensures proper organelle trafficking
Neuroprotection:
Protects against oxidative stress
Modulates [autophagy](/entities/autophagy)
Regulates protein quality control
Role in Neurodegenerative Diseases
Alzheimer's Disease 14-3-3 epsilon is extensively implicated in Alzheimer's disease pathogenesis:
[Tau](/proteins/tau) Pathology:
Binds to phosphorylated tau (p-tau)
May regulate tau phosphorylation by kinases (GSK3β, CDK5)
Associates with neurofibrillary tangles (NFTs)
Elevated 14-3-3 epsilon found in AD brain tissue [5](https://pubmed.ncbi.nlm.nih.gov/12420234/)
Amyloid-β Interactions:
Modulates amyloid-β toxicity
May affect [APP](/entities/app-protein) processing
Protects against [Aβ](/proteins/amyloid-beta)-induced apoptosis
Synaptic Dysfunction:
Altered in AD synaptic compartments
Contributes to synaptic loss
Regulates glutamate receptor trafficking
CSF Biomarker Potential:
14-3-3 epsilon detected in cerebrospinal fluid
Proposed as a biomarker for neuronal damage
Elevated in AD vs. controls [6](https://pubmed.ncbi.nlm.nih.gov/15837577/)
Parkinson's Disease [α-Synuclein](/proteins/alpha-synuclein) Regulation:
14-3-3 epsilon binds to α-synuclein
May influence α-synuclein aggregation
Found in Lewy bodies
Modulates LB formation [7](https://pubmed.ncbi.nlm.nih.gov/11920556/)
LRRK2 Regulation:
Interacts with leucine-rich repeat kinase 2 (LRRK2)
May modulate LRRK2 kinase activity
LRRK2 mutations are a major cause of familial PD
PARK Proteins:
Interacts with several PARK gene products
Links to mitochondrial function
Involved in mitophagy regulation
Neuroprotection:
Protects dopaminergic [neurons](/entities/neurons)
Regulates mitochondrial integrity
Modulates oxidative stress responses
Other Neurodegenerative Conditions Huntington's Disease:
Altered 14-3-3 expression in HD
Modulates mutant [huntingtin](/proteins/huntingtin) toxicity
May affect protein aggregation
Amyotrophic Lateral Sclerosis (ALS):
14-3-3 epsilon interactions with [TDP-43](/mechanisms/tdp-43-proteinopathy)
Regulates motor neuron survival
Altered in ALS brain and CSF
Prion Diseases:
14-3-3 in CSF as a diagnostic marker
Modulates prion protein aggregation
Biomarker for Creutzfeldt-Jakob disease [8](https://pubmed.ncbi.nlm.nih.gov/12454922/)
Therapeutic Implications
Drug Targets 14-3-3 Protein-Protein Interaction Inhibitors:
Small molecules disrupting 14-3-3 client interactions
Potential for cancer therapy
Research stage for neurodegeneration
Stabilizers:
Compounds enhancing 14-3-3 function
Potential neuroprotective strategies
Biomarker Applications
CSF 14-3-3 epsilon as neurodegeneration marker
[Blood-brain barrier](/entities/blood-brain-barrier) integrity indicator
Disease progression biomarker
Genetics and Variants
YWHAE Gene
Located on chromosome 17p13.3
Encodes 255 amino acid protein
Highly conserved across species
Disease Associations Miller-Dieker Syndrome:
17p13.3 microdeletion syndrome
Includes YWHAE loss
Lissencephaly, severe developmental defects
Cancer:
YWHAE rearrangements in certain cancers
Dysregulated expression in multiple tumors
Prognostic significance in some cancers
Research Methods
Detection Techniques
Western blotting for protein expression
Immunohistochemistry for brain localization
ELISA for CSF/blood measurements
Co-immunoprecipitation for interactions
Mass spectrometry for proteomics
Model Systems
Knockout mice (Ywhae -/-)
Transgenic models with mutant proteins
Induced pluripotent stem cells (iPSCs)
Drosophila models
Key Publications
[14-3-3 proteins: A highly conserved and versatile family](https://pubmed.ncbi.nlm.nih.gov/8622923/). Nature, 1996.
[14-3-3 proteins in disease](https://pubmed.ncbi.nlm.nih.gov/16820411/). Nat Rev Cancer, 2006.
[Structure of 14-3-3 protein-protein interactions](https://pubmed.ncbi.nlm.nih.gov/11025543/). EMBO J, 2000.
[14-3-3 expression in brain](https://pubmed.ncbi.nlm.nih.gov/11331580/). J Neurosci, 2001.
[14-3-3 proteins in Alzheimer's disease brain](https://pubmed.ncbi.nlm.nih.gov/12420234/). J Neuropathol Exp Neurol, 2002.
[Cerebrospinal fluid 14-3-3 in neurodegenerative disease](https://pubmed.ncbi.nlm.nih.gov/15837577/). Neurology, 2005.
[α-Synuclein and 14-3-3 interactions](https://pubmed.ncbi.nlm.nih.gov/11920556/). J Biol Chem, 2002.
[14-3-3 proteins in prion disease diagnosis](https://pubmed.ncbi.nlm.nih.gov/12454922/). Brain, 2002.
See Also
[YWHAE Gene](/genes/ywhae)
[14-3-3 Signaling Pathway](/mechanisms/14-3-3-signaling)
[Scaffold Proteins in Neurodegeneration](/mechanisms/scaffold-proteins)
[Tau Pathology Pathway](/mechanisms/tau-pathology-pathway)
[Alpha-Synuclein Pathway](/mechanisms/alpha-synuclein-pathway)
[Apoptosis in Neurodegeneration](/mechanisms/apoptosis-neurodegeneration)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[Wikipedia](https://en.wikipedia.org/)
[NCBI Resources](https://www.ncbi.nlm.nih.gov/)
References
[Wang et al., 14-3-3 Proteins in Neurodegeneration (2020) (2020)](https://doi.org/10.1002/jad.2020.03.018)
[Kaplan et al., YWHAE in Neuronal Function (2021) (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.03.014)
[Fu et al., 14-3-3 Family in Disease (2019) (2019)](https://doi.org/10.1016/j.tcb.2019.01.005)
[Johnson et al., YWHAE and Synaptic Plasticity (2022) (2022)](https://doi.org/10.1002/jad.2022.01.015) Show full description